Allianz Asset Management
BNTX icon

Allianz Asset Management’s BioNTech BNTX Stock Holding History

Allianz Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.81M Sell
54,100
-6,318
-10% -$595K ﹤0.01% 1402
2026
Q1 		$5.37M Buy
60,418
+4,200
+7% +$432K 0.01% 1135
2025
Q4 		$5.35M Sell
56,218
-64,748
-54% -$6.52M 0.01% 1110
2025
Q3 		$11.9M Sell
120,966
-2,529
-2% -$270K 0.01% 772
2025
Q2 		$13.1M Buy
123,495
+2,815
+2% +$284K 0.02% 716
2025
Q1 		$11M Buy
120,680
+37,075
+44% +$4.15M 0.01% 779
2024
Q4 		$9.53M Buy
83,605
+50,805
+155% +$5.8M 0.01% 767
2024
Q3 		$3.9M Buy
32,800
+3,800
+13% +$349K 0.01% 1161
2024
Q2 		$2.33M Hold
29,000
– – ﹤0.01% 1261
2024
Q1 		$2.68M Hold
29,000
– – ﹤0.01% 1086
2023
Q4 		$3.06M Hold
29,000
– – 0.01% 1139
2023
Q3 		$3.15M Hold
29,000
– – 0.01% 1205
2023
Q2 		$3.13M Sell
29,000
-10,300
-26% -$1.16M 0.01% 1081
2023
Q1 		$4.9M Sell
39,300
-15,200
-28% -$2.09M 0.01% 977
2022
Q4 		$8.19M Buy
54,500
+10,900
+25% +$1.68M 0.02% 742
2022
Q3 		$5.88M Sell
43,600
-28,349
-39% -$4.33M 0.01% 828
2022
Q2 		$10.7M Sell
71,949
-7,933
-10% -$1.21M 0.01% 879
2022
Q1 		$13.6M Buy
79,882
+12,880
+19% +$2.16M 0.01% 883
2021
Q4 		$17.3M Sell
67,002
-11,186
-14% -$3.06M 0.01% 812
2021
Q3 		$21.3M Buy
78,188
+32,076
+70% +$10.2M 0.02% 723
2021
Q2 		$10.3M Sell
46,112
-10,963
-19% -$2.07M 0.01% 849
2021
Q1 		$6.23M Buy
57,075
+24,450
+75% +$2.6M 0.01% 981
2020
Q4 		$2.66M Sell
32,625
-27,822
-46% -$2.73M ﹤0.01% 1240
2020
Q3 		$4.18M Buy
60,447
+17,102
+39% +$1.23M ﹤0.01% 1041
2020
Q2 		$2.89M Buy
+43,345
New +$2.16M ﹤0.01% 1451

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Allianz Asset Management's BNTX Position: Q2 2026 in Review

Allianz Asset Management reduced its BioNTech (BNTX) stake by 10% in Q2 2026, selling an estimated $595K and leaving 54,100 shares worth $4.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

Allianz Asset Management first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $21.3M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Allianz Asset Management held 54,100 shares of BioNTech worth $4.81M as of Q2 2026.
  • Allianz Asset Management sold 6,318 BioNTech shares in Q2 2026, an estimated $595K.
  • BioNTech made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1402 holding.
  • Allianz Asset Management first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Allianz Asset Management's BioNTech position peaked at $21.3M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.